凯莫德
CHE
512.38
-3.06
-0.59%
凯莫德
US · CHE
#1837 按市值排名
上市于 1970
512.38
-3.06
-0.59%
实时 - 追踪5344个代码 - 心跳于408秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 105.89% +0.01pp
- 机构数量
- 620
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund79.97%
Hedge Fund13.14%
Public Company5.14%
Private Company2.79%
Government Pension Fund2.37%
Individual/Insider1.47%
Sovereign Wealth Fund1.26%
Insurance Company0.59%
Family Office/Trust0.53%
主要股东 截至 2026-06-30
BlackRock
11.40% · 1.48M 股
AQR Capital Management
7.42% · 965.92K 股
Vanguard Portfolio Management, LLC
6.05% · 787.07K 股
Vanguard Capital Management, LLC
5.29% · 688.38K 股
Acadian Asset Management LLC
3.48% · 453.24K 股
State Street Global Advisors
3.42% · 444.72K 股
Geode Capital Management, LLC
3.18% · 413.94K 股
J.P. Morgan Asset Management, Inc.
2.84% · 369.59K 股
Boston Partners Global Investors, Inc.
2.16% · 280.68K 股
Dimensional Fund Advisors
2.00% · 260.56K 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 23次买入 · 27次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Thomas Hutton | Officer | 0.62% |
| Kevin McNamara | Chief Executive Officer | 0.51% |
| Spencer Lee | Executive Vice President | 0.11% |
| Michael Witzeman | Vice President | 0.05% |
| Andrea Lindell | Independent Director | 0.04% |
| George Walsh | Independent Chairperson | 0.03% |
| Patrick Grace | Independent Director | 0.03% |
| Brian Judkins | VP, Secretary & Chief Legal Officer | 0.03% |
| Christopher Heaney | Independent Director | 0.02% |
| Ron DeLyons | Independent Director | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-29 | Spencer Lee | Executive Vice President | Derivative Exercise and Sale | -11,160 | $445.35–508.93 |
| 2026-09-29 | Spencer Lee | Executive Vice President | Derivative Exercise and Retained | +939 | $445.35 |
| 2026-09-27 | Kevin McNamara | Chief Executive Officer | Open Market Disposition | -2,000 | $513.45 |
| 2026-09-27 | Thomas Hutton | Officer | Derivative Exercise and Sale | -4,270 | $445.35–506.65 |
| 2026-09-27 | Thomas Hutton | Officer | Derivative Exercise and Retained | +359 | $445.35 |
| 2026-09-17 | Kevin McNamara | Chief Executive Officer | Open Market Disposition | -2,000 | $501.40 |
| 2026-08-20 | Kevin McNamara | Chief Executive Officer | Open Market Disposition | -2,000 | $541.16 |
| 2026-08-20 | Spencer Lee | Executive Vice President | Open Market Disposition | -1,000 | $541.04 |
| 2026-08-09 | Brian Judkins | VP, Secretary & Chief Legal Officer | Derivative Exercise and Sale | -5,878 | $445.35–548.96 |
| 2026-08-09 | Brian Judkins | VP, Secretary & Chief Legal Officer | Derivative Exercise and Retained | +908 | $445.35 |
| 2026-08-04 | Joel Wherley | President & CEO of VITAS Healthcare | Derivative Exercise and Sale | -2,270 | $445.35–542.62 |
| 2026-08-04 | Joel Wherley | President & CEO of VITAS Healthcare | Derivative Exercise and Retained | +329 | $445.35 |
| 2026-08-02 | Kevin McNamara | Chief Executive Officer | Open Market Disposition | -2,000 | $539.51 |
| 2026-07-30 | Kevin McNamara | Chief Executive Officer | Sale to Issuer | -17,801 | $529.22 |
| 2026-07-30 | Kevin McNamara | Chief Executive Officer | Derivative Exercise and Sale | -2,001 | $445.35–529.22 |
| 2026-07-30 | Patrick Grace | Independent Director | Open Market Disposition | -190 | $532.00 |
| 2026-06-08 | Andrea Lindell | Independent Director | Open Market Disposition | -1,347 | $447.33 |
| 2026-05-28 | George Walsh | Independent Chairperson | Open Market Disposition | -500 | $437.83 |
| 2026-05-17 | Patrick Grace | Independent Director | Other Acquisition | +386 | $440.77 |
| 2026-05-17 | George Walsh | Independent Chairperson | Other Acquisition | +386 | $440.77 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
凯莫德 讨论区 0 条评论